Acta Scientific Medical Sciences (ISSN: 2582-0931)

Research Article Volume 4 Issue 8

The Influence of Pre-Existing Heart Failure on Community-Acquired Pneumonia Outcomes

Cașcaval Virginia*, Fetco-Mereuță Diana, Caproș Natalia, Grib Livi, Matcovschi Sergiu and Dumitraș Tatiana

Department of Internal Medicine, State University of Medicine and Pharmacy “Nicolae Testemiţanu”, Republic of Moldova

*Corresponding Author: Cașcaval Virginia, Department of Internal Medicine, State University of Medicine and Pharmacy “Nicolae Testemiţanu”, Chișinău, Republic of Moldova.

Received: July 13, 2020; Published: July 21, 2020



Background: Community-acquired pneumonia is a common infectious disease, that is being associated with high mortality, especially in patients with comorbidities, such as heart failure. Also, preexisting heart failure increases pneumonia mortality by 30 - 50%, therefore it is important to identify patients who are in the risk group.

Methods: This is a retrospective study, where we examined causes of death in 62 patients with community-acquired pneumonia and heart failure, with emphasis on clinical, laboratory and microbiological characteristics.

Results: Our results show that cardiovascular disease, especially heart failure, represents a heavy load on the outcomes of community-acquired pneumonia patients and that progression of heart failure, it's complications and other co-morbidities increase the risk of death associated with pneumonia.

Conclusion: The obtained data suggests that community-acquired pneumonia is not only affecting the respiratory system, but it is also a systematic inflammation process that affects the cardiovascular system.

Keywords: Community-Acquired Pneumonia; Heart Failure; Outcomes; Risk Factors; Comorbidities



  1. Corrales-Medina VF., et al. “Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease”. JAMA3 (2015): 264-274.
  2. Corrales-Medina VF., et al. “Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality”. Circulation 6 (2012): 773-781.
  3. Corrales-Medina VF., et al.“Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies”. PLoS Medicine6 (2011): e1001048.
  4. Marta Di Pasquale., et al. “Cardiovascular complications in patients with community-acquired pneumonia”. CAI Journal2 (2017): 23-31.
  5. Yende S., et al. “Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths”. PLoS One8 (2011): e22847.
  6. Perry TW., et al. “Incidence of cardiovascular events after hospital admission for pneumonia”. American Journal of Medicine 124 (2011): 244-251.
  7. Adamuz J., et al. “Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia”. Journal of Infection6 (2014): 34-41.
  8. Bazaz R., et al. “Mechanistic links between acute respiratory tract infections and acute coronary syndromes”. Journal of Infection 1 (2013): 1-17.
  9. Eurich DT., et al. “Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow up”. BMJ 356 (2017): j413.
  10. Corrales-Medina VF., et al. “Role of acute infection in triggering acute coronary syndromes”. Lancet Infection Disease 10 (2010): 83-92.
  11. Eurich DT., et al. “Ten-Year Mortality after Community-acquired Pneumonia: A Prospective Cohort”. American Journal of Respiratory and Critical Care Medicine5 (2015): 597-604.
  12. Holter JC., et al. “Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study”. Plos One2 (2016): e0148741.
  13. Ali Khawaja., et al. “Etiology and outcome of severe community acquired pneumonia in immunocompetent adults”. BMC Infection Disease 94 (2013): 13-94.
  14. Tomashefski JF Jr., et al. “Histopathology and etiology of childhood pneumonia: an autopsy study of 93 patients in Bangladesh”. Pathology 2 (1989): 71-78.
  15. Sirventa JM., et al. „Predictive factors of mortality in severe community-acquired pneumonia: A model with data on the first 24h of ICU admission”. Medicina Intensiva 5 (2013): 308-315.
  16. Darina Miteva, et al. “The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia”. European Respiratory Journal 46 (2015): 59.
  17. Barbara E., et al. “CURB-65 Pneumonia Severity Assessment Adapted for Electronic Decision Support”. Chest 1 (2011): 156-163.
  18. Grant Waterer, et al. “Severity Scores and Community-acquired Pneumonia: Time to Move Forward”. American Journal of Respiratory and Critical Care Medicine 10 (2017): 1236-1238.
  19. Charis A Marwick, et al. “Identifying which septic patients have increased mortality risk using severity scores: a cohort study”. BMC Anesthesiology 14 (2014): 1.
  20. Tamune H., et al. “How can we identify patients with delirium in the emergency department: a review of available screening and diagnostic tools”. American Journal of Emergency Medicine 9 (2017): 1332-1334.
  21. Reimar W Thomsen., et al. "The Impact of Pre-existing Heart Failure on Pneumonia Prognosis: Population-based Cohort Study”. Journal of General Internal Medicine 9 (2008): 1407-1413.
  22. Adamantia Liapikoul., et al. “Multilobar bilateral and unilateral chest radiography involvement: implications for prognosis in hospitalised community acquired pneumonia”. ERJ Express 48 (2016): 257-261.
  23. Fine MJ., et al. “A prediction rule to identify low-risk patients with community-acquired pneumonia”. The New England Journal of Medicine 336 (1997): 243-250.
  24. Lim WS., et al. “Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study”. Thorax 58 (2003): 377-382.
  25. Richard Dwyer., et al. “Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia”. BMJ 1 (2014): 1.


Citation: Cașcaval Virginia., et al. “The Influence of Pre-Existing Heart Failure on Community-Acquired Pneumonia Outcomes".Acta Scientific Medical Sciences 4.8 (2020): 66-70.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

Contact US